While its expression in TNBC is variable, EpCAM overexpression is associated with poor prognosis and may indicate an aggressive tumor phenotype, suggesting its potential as a target for specific therapeutic approaches [13,16,17]. The gene discussed is EPCAM; the disease is neoplasm.